Genetic regulation of osteoclast development and function
- PMID: 12897775
- DOI: 10.1038/nrg1122
Genetic regulation of osteoclast development and function
Abstract
Osteoclasts are the principal, if not exclusive, bone-resorbing cells, and their activity has a profound impact on skeletal health. So, disorders of skeletal insufficiency, such as osteoporosis, typically represent enhanced osteoclastic bone resorption relative to bone formation. Prevention of pathological bone loss therefore depends on an appreciation of the mechanisms by which osteoclasts differentiate from their precursors and degrade the skeleton. The past five years have witnessed important insights into osteoclast formation and function. Many of these discoveries have been made through genetic experiments that involved the rare hereditary disorder osteopetrosis.
Similar articles
-
Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.Bone. 2005 Jan;36(1):159-72. doi: 10.1016/j.bone.2004.09.020. Epub 2004 Nov 24. Bone. 2005. PMID: 15664014
-
Osteoclast differentiation and activation.Nature. 2003 May 15;423(6937):337-42. doi: 10.1038/nature01658. Nature. 2003. PMID: 12748652 Review.
-
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.Cytokine Growth Factor Rev. 2004 Dec;15(6):457-75. doi: 10.1016/j.cytogfr.2004.06.004. Cytokine Growth Factor Rev. 2004. PMID: 15561602 Review.
-
RANKL-RANK signaling in osteoclastogenesis and bone disease.Trends Mol Med. 2006 Jan;12(1):17-25. doi: 10.1016/j.molmed.2005.11.007. Epub 2005 Dec 13. Trends Mol Med. 2006. PMID: 16356770 Review.
-
Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.J Cell Physiol. 2004 Oct;201(1):17-25. doi: 10.1002/jcp.20041. J Cell Physiol. 2004. PMID: 15281085
Cited by
-
Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling.J Cell Biol. 2013 Mar 18;200(6):821-37. doi: 10.1083/jcb.201207154. J Cell Biol. 2013. PMID: 23509071 Free PMC article.
-
Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin.J Clin Invest. 2020 Sep 1;130(9):4811-4830. doi: 10.1172/JCI134214. J Clin Invest. 2020. PMID: 32773408 Free PMC article.
-
Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts.J Bone Miner Res. 2013 Apr;28(4):711-22. doi: 10.1002/jbmr.1885. J Bone Miner Res. 2013. PMID: 23436579 Free PMC article. Review.
-
SLC4A2-mediated Cl-/HCO3- exchange activity is essential for calpain-dependent regulation of the actin cytoskeleton in osteoclasts.Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2163-8. doi: 10.1073/pnas.1206392110. Epub 2013 Jan 22. Proc Natl Acad Sci U S A. 2013. PMID: 23341620 Free PMC article.
-
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis.Int J Mol Sci. 2020 Oct 15;21(20):7623. doi: 10.3390/ijms21207623. Int J Mol Sci. 2020. PMID: 33076329 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous